BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

CASI Pharmaceuticals (Formerly Known As EntreMed, Inc.) 

9620 Medical Center Drive

Rockville  Maryland  20850  U.S.A.
Phone: 240-864-2600 Fax: 301-315-2437


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
CASI Pharmaceuticals  (CASI) Reports First Quarter 2015 Financial Results 5/15/2015 7:22:45 AM
CASI Pharmaceuticals  (CASI) Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3/30/2015 6:01:52 AM
CASI Pharmaceuticals  (CASI) Reports 2014 Fourth Quarter And Full Year Financial Results 3/27/2015 7:31:17 AM
CASI Pharmaceuticals  (CASI) Announces Initiation Of A Phase 2 Trial With ENMD-2076 In Triple-Negative Breast Cancer In China 3/25/2015 6:19:46 AM
CASI Pharmaceuticals  (CASI) Appoints Rong Chen, MD, Ph.D. As Chief Medical Officer 3/4/2015 6:53:04 AM
CASI Pharmaceuticals  (CASI) To Present At The 27th Annual ROTH Conference 3/3/2015 10:28:11 AM
CASI Pharmaceuticals  (CASI) Announces Receipt Of Final Minutes From FDA Meeting Regarding Clinical And Regulatory Path Of ENMD-2076 For The Treatment Of Patients With Fibrolamellar Carcinoma (FLC) 2/9/2015 11:48:22 AM
CASI Pharmaceuticals  (CASI) To Present At The 17th Annual BIO CEO & Investor Conference 2/2/2015 11:41:22 AM
CASI Pharmaceuticals  (CASI) Highlights 2014 Accomplishments And 2015 Milestones 1/16/2015 9:48:47 AM
CASI Pharmaceuticals  (CASI) To Hold Business Update Conference Call And Webcast On January 6th 12/23/2014 8:19:29 AM
12345678910...